U.S. Seeks to Boost Experimental Ebola Drug Production

October 18, 2014 8:55 AM

16 0

U.S. health officials have requested laboratories to submit plans of increasing the production of Zmapp, the experimental Ebola drug, after supplies ran out. Although the drug hasn’t been widely tested, it had positive results when being used to treat medical workers infected with the hemorrhagic fever virus.

On Thursday, an order was issued by the U.S. Department of Health and Human services through its BARDA division that the antiviral cocktail starts to be mass produced. A deadline has been given to three advanced biological laboratories capable of producing the drug. Until November 10th, they have to...

Read more

To category page